183 related articles for article (PubMed ID: 17163278)
1. Serum levels and possible haemodynamic effects following anorectal application of an ointment containing nifedipine and lignocaine : a study in healthy volunteers.
Perrotti P; Grumetto L; Barbato F; Antropoli C
Clin Drug Investig; 2006; 26(8):459-67. PubMed ID: 17163278
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of anorectal nifedipine and lidocaine (lignocaine) ointment following haemorrhoidectomy: an open-label, single-dose, phase IV clinical study.
Perrotti P; Dominici P; Grossi E; Antropoli C; Giannotti G; Cusato M; Regazzi M; Cerutti R
Clin Drug Investig; 2009; 29(4):243-56. PubMed ID: 19301938
[TBL] [Abstract][Full Text] [Related]
3. Proof of systemic safety of a lidocaine ointment in the treatment of patients with anorectal pain.
Zimmermann J; Schlegelmilch R; Mazur D; Seiler D; Vens-Cappell B
Arzneimittelforschung; 2007; 57(1):12-9. PubMed ID: 17341004
[TBL] [Abstract][Full Text] [Related]
4. Topical nifedipine with lidocaine ointment versus active control for pain after hemorrhoidectomy: results of a multicentre, prospective, randomized, double-blind study.
Perrotti P; Dominici P; Grossi E; Cerutti R; Antropoli C
Can J Surg; 2010 Feb; 53(1):17-24. PubMed ID: 20100408
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic evaluation of a nanotechnological topical formulation of lidocaine/prilocaine (nanorap) in healthy volunteers.
Gagliano-Jucá T; Castelli MR; Mendes GD; Arruda AM; Chen LS; de Oliveira MA; Costa SF; Lopes AG; de Souza W; De Nucci G
Ther Drug Monit; 2015 Jun; 37(3):362-8. PubMed ID: 25525759
[TBL] [Abstract][Full Text] [Related]
6. Systemic levels of glyceryl trinitrate following topical application to the anoderm do not correlate with the measured reduction in anal pressure.
Jonas M; Barrett DA; Shaw PN; Scholefield JH
Br J Surg; 2001 Dec; 88(12):1613-6. PubMed ID: 11736974
[TBL] [Abstract][Full Text] [Related]
7. The effect of topical nifedipine in treatment of chronic anal fissure.
Golfam F; Golfam P; Khalaj A; Sayed Mortaz SS
Acta Med Iran; 2010; 48(5):295-9. PubMed ID: 21287460
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of EMLA cream 5% application to oral mucosa.
Vickers ER; Marzbani N; Gerzina TM; McLean C; Punnia-Moorthy A; Mather L
Anesth Prog; 1997; 44(1):32-7. PubMed ID: 9481979
[TBL] [Abstract][Full Text] [Related]
9. Serum lidocaine levels and cutaneous side effects after application of 23% lidocaine 7% tetracaine ointment to the face.
McCleskey PE; Patel SM; Mansalis KA; Elam AL; Kinsley TR
Dermatol Surg; 2013 Jan; 39(1 Pt 1):82-91. PubMed ID: 23278914
[TBL] [Abstract][Full Text] [Related]
10. Comparison of topical glyceryl trinitrate with lignocaine ointment for treatment of anal fissure: a randomised controlled trial.
Ahmad J; Andrabi SI; Rathore MA
Int J Surg; 2007 Dec; 5(6):429-32. PubMed ID: 17869598
[TBL] [Abstract][Full Text] [Related]
11. Impact of perioperative lidocaine infusion and bis monitorization on remifentanil dosage in hypotensive anesthesia.
Uzun S; Yuce Y; Erden A; Aypar U
Eur Rev Med Pharmacol Sci; 2014; 18(4):559-65. PubMed ID: 24610623
[TBL] [Abstract][Full Text] [Related]
12. Effects of intravenous lidocaine overdose on cardiac electrical activity and blood pressure in the horse.
Meyer GA; Lin HC; Hanson RR; Hayes TL
Equine Vet J; 2001 Sep; 33(5):434-7. PubMed ID: 11558736
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and safety of continuously applied lidocaine patches 5%.
Gammaitoni AR; Alvarez NA; Galer BS
Am J Health Syst Pharm; 2002 Nov; 59(22):2215-20. PubMed ID: 12455305
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
Gammaitoni AR; Davis MW
Ann Pharmacother; 2002 Feb; 36(2):236-40. PubMed ID: 11847940
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Lidocaine and Its Metabolites Following Vaginal Administration of Lidocaine Gel to Healthy Female Subjects.
Martell B; Kushner H; Richardson E; Mize A; Mayer P
Clin Pharmacol Drug Dev; 2017 Jan; 6(1):27-35. PubMed ID: 27297519
[TBL] [Abstract][Full Text] [Related]
16. Plasma lignocaine concentration following nebulization for awake intubation.
Parkes SB; Butler CS; Muller R
Anaesth Intensive Care; 1997 Aug; 25(4):369-71. PubMed ID: 9288379
[TBL] [Abstract][Full Text] [Related]
17. Lidocaine anal block limits autonomic dysreflexia during anorectal procedures in spinal cord injury: a randomized, double-blind, placebo-controlled trial.
Cosman BC; Vu TT
Dis Colon Rectum; 2005 Aug; 48(8):1556-61. PubMed ID: 15991060
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
[TBL] [Abstract][Full Text] [Related]
19. Correlation of plasma levels of nifedipine and cardiovascular effects after sublingual dosing in normal subjects.
Traube M; Hongo M; McAllister RG; McCallum RW
J Clin Pharmacol; 1985 Mar; 25(2):125-9. PubMed ID: 3886708
[TBL] [Abstract][Full Text] [Related]
20. Lignocaine plasma levels following topical gel application in laparoscopic and hysteroscopic procedures.
Hewitt EA; Armstrong G; Beg N; Katz S; Vancaillie TG
Anaesth Intensive Care; 2012 Mar; 40(2):292-6. PubMed ID: 22417024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
